IIT resch institute:1107221 [18-005715] to perform the study "single PO dose cardiovascular and pulmonary safety pharmacology study of metarrestin in telemetered beagle dogs using latin-square cross…
Ended Awarded Last action
- Contract number
- 75N95018F00003
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $130,093
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR172002 · Posted Apr 7, 2020
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Award Notice · Posted May 2, 2016
- Contract value 100% obligated
- $130,092.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$9,390 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $139,483 |
About this award
This delivery order was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to IIT Research Institute under the CRO Support for NCATS In Vitro and In Vivo Toxicology Studies contract vehicle. IIT Research Institute will perform a single-dose cardiovascular and pulmonary safety pharmacology study of Metarrestin in telemetered beagle dogs using a Latin square crossover study design. The $130,092.52 cost-plus-fixed-fee contract is funded by HHS-NIH/NCATS and will be performed in Chicago, Illinois over the period from July 15, 2018 to February 28, 2019. No subcontractors or set aside designations were identified. The study appears intended to assess the safety of Metarrestin, advancing NCATS' mission to translate scientific discoveries into clinical applications.
Description
IIT resch institute:1107221 [18-005715] to perform the study "single PO dose cardiovascular and pulmonary safety pharmacology study of metarrestin in telemetered beagle dogs using latin-square cross over study design".
Quick answers
Who was awarded contract 75N95018F00003?
75N95018F00003 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on July 15, 2018.
How much is contract 75N95018F00003 worth?
The government has obligated $130,093 on 75N95018F00003.
Which agency awarded contract 75N95018F00003?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95018F00003, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95018F00003 an order under another contract?
Yes. 75N95018F00003 is a delivery order under HHSN271201700016I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract 75N95018F00003 competed?
The extent of competition for 75N95018F00003 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award